Deltic Energy Share Discount Widens as AIM Thinness Tests Cash Offer
Markets Daniel Marsh

Deltic Energy Share Discount Widens as AIM Thinness Tests Cash Offer

Deltic Energy shares remain below the 7.7p cash offer from NEO NEXT+, with thin AIM liquidity widening the bid spread. Peel Hunt trades reveal the real market gap.

SHEL
TELUS shares hit new low as new CEO faces high-yield dividend challenge
Markets Daniel Marsh

TELUS shares hit new low as new CEO faces high-yield dividend challenge

TELUS shares dropped 1.77% to a new 52-week low of CA$14.71 on Thursday, as new CEO Victor Dodig takes the helm. The stock's dividend yield of 11.36% is more than double that of BCE and Rogers, highlighting the challenge of sustaining payouts.

BCE
BlackBerry Shares Retreat as Note Conversion Weighs on Valuation
Markets Daniel Marsh

BlackBerry Shares Retreat as Note Conversion Weighs on Valuation

BlackBerry shares dropped 8.8% as a convertible note conversion window opened, raising dilution concerns despite strong QNX revenue growth.

BB
Gold Surges Past $4,100 on Weak US Jobs Data, Fed Rate Cut Hopes
Commodities Rebecca Torres

Gold Surges Past $4,100 on Weak US Jobs Data, Fed Rate Cut Hopes

Gold surged past $4,100 after weaker-than-expected US jobs data and downward revisions to prior months fueled hopes for Federal Reserve rate cuts. Spot gold rose 2.4% to $4,126.97.

GLD ADP CME
Oracle's AI Backlog Surpasses $638B, But Spending Outpaces Revenue
Technology Sarah Chen

Oracle's AI Backlog Surpasses $638B, But Spending Outpaces Revenue

Oracle's AI backlog reaches $638 billion, exceeding Microsoft's, but its market cap is just one-seventh. Heavy capex plans raise questions about funding and revenue conversion.

ORCL MSFT
AMD Shares Dip Despite Bullish Analyst Targets, Focus Shifts to CPU Revenue Potential
Technology Sarah Chen

AMD Shares Dip Despite Bullish Analyst Targets, Focus Shifts to CPU Revenue Potential

AMD shares slipped 3.5% despite bullish analyst targets, as the market weighs the potential of its server CPU business to support a near-trillion-dollar valuation.

AMD META INTC WFC UBS NVDA
Big Tree Cloud Volume Surges 3.7x Float Before Holiday Break
Markets Daniel Marsh

Big Tree Cloud Volume Surges 3.7x Float Before Holiday Break

Big Tree Cloud (DSY) surged 50.7% on volume 3.7 times its total shares, with no news catalyst. The stock's valuation now exceeds 40 times revenue.

DSY IWM XLP
Apple Rally Narrows Upside as AI Upgrade Hopes Falter
Technology Sarah Chen

Apple Rally Narrows Upside as AI Upgrade Hopes Falter

Apple surged 3.9% to $305.81, adding $168B in market cap, but UBS data reveals Apple Intelligence hasn't accelerated iPhone upgrades, capping near-term upside.

AAPL QQQ SPY NVDA META TSLA MSFT AMZN GOOGL
Tesla Shares Slide Despite Q2 Delivery Beat on Inventory Reduction
Markets Daniel Marsh

Tesla Shares Slide Despite Q2 Delivery Beat on Inventory Reduction

Tesla shares dropped 6.8% after Q2 deliveries beat consensus by 74,102 vehicles, but the beat was partly due to an inventory drawdown. Investors now focus on July 22 earnings.

TSLA RIVN GM F QQQ SPY
Dow Leads Market Rally After Soft Jobs Data, Nears Record Close
Markets Daniel Marsh

Dow Leads Market Rally After Soft Jobs Data, Nears Record Close

The Dow Jones Industrial Average jumped 435 points after weaker-than-expected June jobs data eased rate-hike concerns, with the blue-chip index nearing a record close.

NKE BA GOOGL VZ
Wall Street Edges Higher as Weak Jobs Data Eases Rate Hike Fears
Markets Daniel Marsh

Wall Street Edges Higher as Weak Jobs Data Eases Rate Hike Fears

US stocks rose Thursday after June payrolls missed expectations, easing fears of further Fed rate hikes. The Dow jumped 447 points, but semiconductor and tech ETFs declined.

SPY QQQ XLK SOXX XLP XLB AAPL MSFT NVDA AMD MU FIZZ
Regencell Bioscience Shares Slide 63% Below May Offering Price
Markets Daniel Marsh

Regencell Bioscience Shares Slide 63% Below May Offering Price

Regencell Bioscience (NASDAQ:RGC) dropped 6.6% to $7.50, remaining 63.1% below its May offering price, despite a brief intraday rebound. Biotech ETFs gained.

RGC IBB XBI QQQ